Panic disorder: an app used alongside medication appears to reduce symptoms
A randomized trial suggests a benefit from adding a therapeutic app to medication for panic disorder, with follow-up limited to eight weeks.
Read the newsThe news feed
Recent studies and announcements, explained with the same rigor as our analyses: sources, context, and the limitations of the data.
The publication feed
Predicting jaw growth with AI: results still insufficient for clinical practice
A review of twelve studies examines AI-based prediction of craniofacial growth. Its superiority over conventional statistical methods remains to be established.
MicroRNAs and neurological diseases: a promising review, but exclusively preclinical
A review of 37 studies explores microRNAs derived from mesenchymal stem cells in Parkinson’s, Alzheimer’s and stroke. No benefit in humans has been established.
Digital cognitive training: potential lasting benefits in older adults with mild impairment
A trial suggests sustained benefits after 20 hours of digital cognitive training, but their magnitude and the advantage over games remain unclear.